91 related articles for article (PubMed ID: 37501156)
1. Why estimands are needed to define treatment effects in clinical trials.
Keene ON; Lynggaard H; Englert S; Lanius V; Wright D
BMC Med; 2023 Jul; 21(1):276. PubMed ID: 37501156
[TBL] [Abstract][Full Text] [Related]
2. Adherence, per-protocol effects, and the estimands framework.
Keene O
Pharm Stat; 2023; 22(6):1141-1144. PubMed ID: 37477077
[TBL] [Abstract][Full Text] [Related]
3. Estimands in published protocols of randomised trials: urgent improvement needed.
Kahan BC; Morris TP; White IR; Carpenter J; Cro S
Trials; 2021 Oct; 22(1):686. PubMed ID: 34627347
[TBL] [Abstract][Full Text] [Related]
4. Evaluating how clear the questions being investigated in randomised trials are: systematic review of estimands.
Cro S; Kahan BC; Rehal S; Chis Ster A; Carpenter JR; White IR; Cornelius VR
BMJ; 2022 Aug; 378():e070146. PubMed ID: 35998928
[TBL] [Abstract][Full Text] [Related]
5. Application of the Estimand Framework to Anesthesia Trials.
De Silva AP; Leslie K; Braat S; Grobler AC
Anesthesiology; 2024 Jul; 141(1):13-23. PubMed ID: 38743905
[TBL] [Abstract][Full Text] [Related]
6. Starting a conversation about estimands with public partners involved in clinical trials: a co-developed tool.
Cro S; Kahan BC; Patel A; Henley A; C J; Hellyer P; Kumar M; Rahman Y; Goulão B
Trials; 2023 Jul; 24(1):443. PubMed ID: 37408080
[TBL] [Abstract][Full Text] [Related]
7. Defining estimands for efficacy assessment in single arm phase 1b or phase 2 clinical trials in oncology early development.
Englert S; Mercier F; Pilling EA; Homer V; Habermehl C; Zimmermann S; Kan-Dobrosky N
Pharm Stat; 2023; 22(5):921-937. PubMed ID: 37403434
[TBL] [Abstract][Full Text] [Related]
8. Estimands for clinical endpoints in tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial.
Weir IR; Dufault SM; Phillips PPJ
Trials; 2024 Mar; 25(1):180. PubMed ID: 38468320
[TBL] [Abstract][Full Text] [Related]
9. Time-to-event estimands and loss to follow-up in oncology in light of the estimands guidance.
Siegel JM; Weber HJ; Englert S; Liu F; Casey M;
Pharm Stat; 2024 Mar; ():. PubMed ID: 38553421
[TBL] [Abstract][Full Text] [Related]
10. Estimands for clinical endpoints in Tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial.
Weir IR; Dufault SM; Phillips PP
Res Sq; 2023 Nov; ():. PubMed ID: 37986887
[TBL] [Abstract][Full Text] [Related]
11. Estimand for non-inferiority influenza vaccine immunogenicity trials.
Nauta J
Vaccine; 2024 Feb; 42(4):840-843. PubMed ID: 38220488
[TBL] [Abstract][Full Text] [Related]
12. Duration of and time to response in oncology clinical trials from the perspective of the estimand framework.
Weber HJ; Corson S; Li J; Mercier F; Roychoudhury S; Sailer MO; Sun S; Todd A; Yung G;
Pharm Stat; 2024; 23(1):91-106. PubMed ID: 37786317
[TBL] [Abstract][Full Text] [Related]
13. Estimands in CNS trials - A review of strategies for addressing intercurrent events.
Mészáros L; Lasch F; Delafont B; Guizzaro L
Contemp Clin Trials Commun; 2024 Apr; 38():101266. PubMed ID: 38380344
[TBL] [Abstract][Full Text] [Related]
14. Reflections on estimands for patient-reported outcomes in cancer clinical trials.
Lawrance R; Skaltsa K; Regnault A; Floden L
J Biopharm Stat; 2023 Nov; ():1-11. PubMed ID: 37980609
[TBL] [Abstract][Full Text] [Related]
15. [Special issue PRO] A demonstration of estimands and sensitivity analyses for time-to-deterioration of patient reported outcomes.
Floden L; DeRosa M; Roydhouse J; Beaumont JL; Hudgens S
J Biopharm Stat; 2024 Apr; ():1-15. PubMed ID: 38686622
[TBL] [Abstract][Full Text] [Related]
16. Understanding estimands.
Gogtay NJ; Ranganathan P; Aggarwal R
Perspect Clin Res; 2021; 12(2):106-112. PubMed ID: 34012908
[TBL] [Abstract][Full Text] [Related]
17. Estimands: bringing clarity and focus to research questions in clinical trials.
Clark TP; Kahan BC; Phillips A; White I; Carpenter JR
BMJ Open; 2022 Jan; 12(1):e052953. PubMed ID: 34980616
[TBL] [Abstract][Full Text] [Related]
18. Demystifying estimands in cluster-randomised trials.
Kahan BC; Blette BS; Harhay MO; Halpern SD; Jairath V; Copas A; Li F
Stat Methods Med Res; 2024 May; ():9622802241254197. PubMed ID: 38780480
[TBL] [Abstract][Full Text] [Related]
19. Prediction meets causal inference: the role of treatment in clinical prediction models.
van Geloven N; Swanson SA; Ramspek CL; Luijken K; van Diepen M; Morris TP; Groenwold RHH; van Houwelingen HC; Putter H; le Cessie S
Eur J Epidemiol; 2020 Jul; 35(7):619-630. PubMed ID: 32445007
[TBL] [Abstract][Full Text] [Related]
20. What is an estimand & how does it relate to quantifying the effect of treatment on patient-reported quality of life outcomes in clinical trials?
Lawrance R; Degtyarev E; Griffiths P; Trask P; Lau H; D'Alessio D; Griebsch I; Wallenstein G; Cocks K; Rufibach K
J Patient Rep Outcomes; 2020 Aug; 4(1):68. PubMed ID: 32833083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
